Cargando…
Avelumab inducing hypothyroidism and hypoadrenalism: A case report and review of literature
Avelumab is an anti-PD-L1 (programmed death-ligand 1) immune checkpoint inhibitor (ICIs) and the monoclonal antibody that constitutes a major development in the immunotherapy of cancer. In 2017, The European Medicine Agency (EMA) approved it as an orphan drug for treatment of gastric cancer. Aveluma...
Autores principales: | Aziz, Kashif, Shahbaz, Amir, Umair, Muhammad, Sachmechi, Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046621/ https://www.ncbi.nlm.nih.gov/pubmed/30034316 http://dx.doi.org/10.17179/excli2018-1357 |
Ejemplares similares
-
Hyperprolactinemia with Galactorrhea Due to Subclinical Hypothyroidism: A Case Report and Review of Literature
por: Aziz, Kashif, et al.
Publicado: (2018) -
Acute Liver Injury Induced by Sitagliptin: Report of Two Cases and Review of Literature
por: Shahbaz, Amir, et al.
Publicado: (2018) -
Prolonged Duration of Hashitoxicosis in a Patient with Hashimoto’s Thyroiditis: A Case Report and Review of Literature
por: Shahbaz, Amir, et al.
Publicado: (2018) -
Graves' Disease Presenting as Painful Goiter: A Case Report and Review of the Literature
por: Shahbaz, Amir, et al.
Publicado: (2018) -
Improvement of Chronic Idiopathic Urticaria With Levothyroxine: A Case Report and Review of Literature
por: Shahbaz, Amir, et al.
Publicado: (2018)